The Bronx, NY 的 鐮狀細胞病 臨床試驗
8 項針對 鐮狀細胞病 的研究正在 The Bronx（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Childrens Hospital at Montefiore, The Bronx
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- Jacobi Medical Center, The Bronx
- Montefiore Medical Ctr, The Bronx
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
招募中2/3 期
- Jacobi Medical Center, The Bronx
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中觀察性研究
- Montefiore Medical Center, The Bronx
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
招募中2 期
- Jacobi Medical Center, The Bronx
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
招募中2 期
- Jacobi Medical Center, The Bronx
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
招募中3 期
- Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
招募中觀察性研究
- Children's Hospital at Montefiore (MRD HCT), The Bronx
- Children's Hospital at Montefiore (NT-DMT), The Bronx
其他城市的 鐮狀細胞病 試驗
- Atlanta, GA22 項研究
- Washington, DC20 項研究
- Chicago, IL18 項研究
- Memphis, TN18 項研究
- Philadelphia, PA15 項研究
- Birmingham, AL14 項研究
- New York City, NY13 項研究
- St. Louis, MO12 項研究
- Boston, MA10 項研究
- Durham, NC10 項研究
- Houston, TX10 項研究
- Cincinnati, OH10 項研究
The Bronx 的其他研究
- 非小細胞肺癌25 項研究
- 乳癌17 項研究
- 急性髓系白血病15 項研究
- 肺癌13 項研究
- 癌症（所有類型）12 項研究
- 心血管疾病12 項研究
- 心臟衰竭11 項研究
- 前列腺癌11 項研究
- 轉移性癌症9 項研究
- 大腸直腸癌9 項研究
- 頭頸部鱗狀細胞癌9 項研究
- 骨髓增生異常症候群9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。